NVAX (novavax.com) Rasio nilai perusahaan marang pendapatan

Logo perusahaan publik Novavax Inc (NVAX)

Complex cold chain logistics increase delivery costs for Novavax, Inc. (NVAX), creating volatility as reflected in the EV/Sales multiple chart. The latest value is recorded as 2299.94. Stability is provided by a strategy to transition toward commercial protein vaccines supported by a global alliance. Simultaneously, Novavax, Inc. (NVAX) is optimizing costs by switching contract manufacturers and implementing a seamless outsourcing management model.

NVAX Nilai perusahaan marang pendapatan Novavax Pharma (23.11.2025 - 20.11.2026)

Rincian metrik keuangan lan pasar Novavax, Inc. (NVAX)

- rega lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
Pambiji fundamental:Novavax, Inc. NVAX
Produk seri Novavax Pharma

Novavax, Inc. (NVAX) is transforming its business model, shifting from COVID-19 products toward combination vaccines and licensing. By analyzing the enterprise value-to-annual revenue multiple, an investor assesses the market value of the business excluding debt load. This chart reflects the efficiency of operational growth relative to capitalization. A decline in this metric confirms the fundamental strengthening of the company's position, allowing analysts to strip away share price volatility when valuing real assets.